Abstract
We have investigated possible factors that underlie changes in the production of eicosanoids after prolonged exposure of mast cells to Ag. Ag stimulation of cultured RBL-2H3 mast cells resulted in increased expression of cyclooxygenase (COX-2) protein and message. Other eicosanoid-related enzymes, namely COX-1, 5-lipoxygenase, and cytosolic phospholipase A(2) were not induced. Activation of extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein (MAP) kinase preceded the induction of COX-2, whereas phosphatidylinositol 3' kinase and its substrate, Akt, were constitutively activated in RBL-2H3 cells. Studies with pharmacologic inhibitors indicated that of these kinases, only p38 MAP kinase regulated expression of COX-2. The induction of COX-2 was blocked by the p38 MAP kinase inhibitor SB202190, even when added 12-16 h after stimulation with Ag when p38 MAP kinase activity had returned to near basal, but still minimally elevated, levels. Interestingly, expression of COX-2 as well as cytosolic phospholipase A(2) and 5-lipoxygenase were markedly reduced by SB202190 in unstimulated cells. Collectively, the results imply that p38 MAP kinase regulates expression of eicosanoid-related enzymes, passively or actively, at very low levels of activity in RBL-2H3 cells. Also, comparison with published data suggest that different MAP kinases regulate induction of COX-2 in inflammatory cells of different and even similar phenotype and suggest caution in extrapolating results from one type of cell to another.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antigens / immunology*
-
Arachidonate 5-Lipoxygenase / biosynthesis
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
Dexamethasone / pharmacology
-
Dinitrophenols / immunology
-
Dose-Response Relationship, Immunologic
-
Enzyme Activation / immunology
-
Enzyme Induction / immunology
-
Enzyme Inhibitors / pharmacology
-
Imidazoles / pharmacology
-
Isoenzymes / antagonists & inhibitors
-
Isoenzymes / biosynthesis*
-
JNK Mitogen-Activated Protein Kinases
-
Lipoxygenase Inhibitors
-
MAP Kinase Signaling System / immunology
-
Mast Cells / drug effects
-
Mast Cells / enzymology*
-
Mast Cells / immunology*
-
Membrane Proteins
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / metabolism*
-
Mitogen-Activated Protein Kinases / physiology
-
Phospholipases A / antagonists & inhibitors
-
Phospholipases A / biosynthesis
-
Phosphorylation
-
Prostaglandin-Endoperoxide Synthases / biosynthesis*
-
Pyridines / pharmacology
-
Rats
-
Serum Albumin, Bovine / immunology
-
Tumor Cells, Cultured
-
p38 Mitogen-Activated Protein Kinases
Substances
-
Antigens
-
Dinitrophenols
-
Enzyme Inhibitors
-
Imidazoles
-
Isoenzymes
-
Lipoxygenase Inhibitors
-
Membrane Proteins
-
Pyridines
-
dinitrophenyl-bovine serum albumin
-
Serum Albumin, Bovine
-
Dexamethasone
-
Arachidonate 5-Lipoxygenase
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
Ptgs1 protein, rat
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
Phospholipases A
-
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole